Trial Details
COMPLETEDBasic Information
| Clinical ID | c1043 |
|---|---|
| Identifier | NCT01290042 |
| Trial Title | Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181. |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease |
| Interventions | DRUG: AMG 181|OTHER: Placebo for AMG 181 |
Participant Information
| Sponsor | Amgen |
|---|---|
| City | Glendale |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2025-02-11 |
|---|---|
| Primary Completion Date | 2025-04-14 |
| Completion Date | 2025-05-14 |